
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus–Driven Production of a Bispecific T-cell Engager
Anna Wing, Carlos Alberto Fajardo, Avery D. Posey, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 5, pp. 605-616
Open Access | Times Cited: 221
Anna Wing, Carlos Alberto Fajardo, Avery D. Posey, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 5, pp. 605-616
Open Access | Times Cited: 221
Showing 1-25 of 221 citing articles:
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq, Christopher S. Hackett, Renier J. Brentjens
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 3, pp. 147-167
Open Access | Times Cited: 1123
Sarwish Rafiq, Christopher S. Hackett, Renier J. Brentjens
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 3, pp. 147-167
Open Access | Times Cited: 1123
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn, Maarten L. Janmaat, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 8, pp. 585-608
Closed Access | Times Cited: 985
Aran F. Labrijn, Maarten L. Janmaat, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 8, pp. 585-608
Closed Access | Times Cited: 985
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C. Larson, Marcela V. Maus
Nature reviews. Cancer (2021) Vol. 21, Iss. 3, pp. 145-161
Open Access | Times Cited: 633
Rebecca C. Larson, Marcela V. Maus
Nature reviews. Cancer (2021) Vol. 21, Iss. 3, pp. 145-161
Open Access | Times Cited: 633
Improving cancer immunotherapy through nanotechnology
Michael S. Goldberg
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 587-602
Closed Access | Times Cited: 526
Michael S. Goldberg
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 587-602
Closed Access | Times Cited: 526
T cell-engaging therapies — BiTEs and beyond
Maria-Elisabeth Goebeler, Ralf C. Bargou
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 7, pp. 418-434
Closed Access | Times Cited: 446
Maria-Elisabeth Goebeler, Ralf C. Bargou
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 7, pp. 418-434
Closed Access | Times Cited: 446
Exploiting the folate receptor α in oncology
Mariana Scaranti, Elena Cojocaru, Susana Banerjee, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 6, pp. 349-359
Closed Access | Times Cited: 414
Mariana Scaranti, Elena Cojocaru, Susana Banerjee, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 6, pp. 349-359
Closed Access | Times Cited: 414
Navigating CAR-T cells through the solid-tumour microenvironment
Andrew J. Hou, Laurence C. Chen, Yvonne Y. Chen
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 531-550
Open Access | Times Cited: 366
Andrew J. Hou, Laurence C. Chen, Yvonne Y. Chen
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 531-550
Open Access | Times Cited: 366
Adoptive cellular therapies: the current landscape
Maartje W. Rohaan, Sofie Wilgenhof, John B.A.G. Haanen
Virchows Archiv (2018) Vol. 474, Iss. 4, pp. 449-461
Open Access | Times Cited: 346
Maartje W. Rohaan, Sofie Wilgenhof, John B.A.G. Haanen
Virchows Archiv (2018) Vol. 474, Iss. 4, pp. 449-461
Open Access | Times Cited: 346
Emerging Cellular Therapies for Cancer
Sònia Guedan, Marco Ruella, Carl H. June
Annual Review of Immunology (2018) Vol. 37, Iss. 1, pp. 145-171
Open Access | Times Cited: 324
Sònia Guedan, Marco Ruella, Carl H. June
Annual Review of Immunology (2018) Vol. 37, Iss. 1, pp. 145-171
Open Access | Times Cited: 324
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Molecular Therapy (2020) Vol. 28, Iss. 11, pp. 2320-2339
Open Access | Times Cited: 293
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Molecular Therapy (2020) Vol. 28, Iss. 11, pp. 2320-2339
Open Access | Times Cited: 293
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 284
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 284
Oncolytic viruses for cancer immunotherapy
Otto Hemminki, João M. Santos, Akseli Hemminki
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 255
Otto Hemminki, João M. Santos, Akseli Hemminki
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 255
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
Alba Rodríguez-García, Asís Palazón, Estela Noguera-Ortega, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 240
Alba Rodríguez-García, Asís Palazón, Estela Noguera-Ortega, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 240
Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
Keisuke Watanabe, Shunichiro Kuramitsu, Avery D. Posey, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 220
Keisuke Watanabe, Shunichiro Kuramitsu, Avery D. Posey, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 220
Engineered cellular immunotherapies in cancer and beyond
Amanda Finck, Tatiana Blanchard, Christopher P. Roselle, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 678-689
Open Access | Times Cited: 208
Amanda Finck, Tatiana Blanchard, Christopher P. Roselle, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 678-689
Open Access | Times Cited: 208
CARs versus BiTEs: A Comparison between T Cell–Redirection Strategies for Cancer Treatment
Clare Y. Slaney, Pin Wang, Phillip K. Darcy, et al.
Cancer Discovery (2018) Vol. 8, Iss. 8, pp. 924-934
Closed Access | Times Cited: 201
Clare Y. Slaney, Pin Wang, Phillip K. Darcy, et al.
Cancer Discovery (2018) Vol. 8, Iss. 8, pp. 924-934
Closed Access | Times Cited: 201
Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors
Anthony K. Park, Yuman Fong, Sang‐In Kim, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 559
Open Access | Times Cited: 196
Anthony K. Park, Yuman Fong, Sang‐In Kim, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 559
Open Access | Times Cited: 196
Engineering strategies to enhance oncolytic viruses in cancer immunotherapy
Yaomei Tian, Daoyuan Xie, Yang Li
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 160
Yaomei Tian, Daoyuan Xie, Yang Li
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 160
Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment
Tao Shi, Xueru Song, Yue Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 140
Tao Shi, Xueru Song, Yue Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 140
CAR-T: What Is Next?
Yi‐Ju Chen, Bams Abila, Yasser Mostafa Kamel
Cancers (2023) Vol. 15, Iss. 3, pp. 663-663
Open Access | Times Cited: 140
Yi‐Ju Chen, Bams Abila, Yasser Mostafa Kamel
Cancers (2023) Vol. 15, Iss. 3, pp. 663-663
Open Access | Times Cited: 140
The present and future of bispecific antibodies for cancer therapy
Christian Klein, Ulrich Brinkmann, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 301-319
Closed Access | Times Cited: 124
Christian Klein, Ulrich Brinkmann, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 301-319
Closed Access | Times Cited: 124
Probiotic-guided CAR-T cells for solid tumor targeting
Rosa L. Vincent, Candice R. Gurbatri, Fangda Li, et al.
Science (2023) Vol. 382, Iss. 6667, pp. 211-218
Open Access | Times Cited: 111
Rosa L. Vincent, Candice R. Gurbatri, Fangda Li, et al.
Science (2023) Vol. 382, Iss. 6667, pp. 211-218
Open Access | Times Cited: 111
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 100
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 100
CAR-T cell combination therapy: the next revolution in cancer treatment
Maysoon Al‐Haideri, Santalia Banne Tondok, Salar Hozhabri Safa, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Maysoon Al‐Haideri, Santalia Banne Tondok, Salar Hozhabri Safa, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
Atheer Khdyair Hamad, Gaukhar M. Yusubalieva, Владимир П. Баклаушев, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 547-547
Open Access | Times Cited: 58
Atheer Khdyair Hamad, Gaukhar M. Yusubalieva, Владимир П. Баклаушев, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 547-547
Open Access | Times Cited: 58